Research Banner


Neurodegenerative diseases represent some of the most significant public health challenges of the 21st century: they are chronic, common and untreatable. 

Today, one-third of adults over 85 years of age have some form of dementia. As our population ages over the next 25 years, the prevalence of these diseases is expected to double.

The science of these diseases is complex – the easy answers have been ruled out. 

At the Tanz Centre, we are prepared to meet this challenge. Our researchers have made many of the most important discoveries of the past two decades concerning the genetics of Alzheimer’s and other diseases. We are determined to discover and invent effective diagnostics and therapies that will stop these devastating diseases.

To learn more about our research areas and the science behind the neurodegenerative diseases studied at the Tanz Centre, please explore the links below:

Jan 21, 2022
An international research team that includes a University of Toronto scientist is deepening our understanding of a defining characteristic in Alzheimer’s and many neurodegenerative diseases: a protein called tau.
Dec 15, 2021
Martin Ingelsson recently moved to Canada from his native Sweden to join the research team in the Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto and the Krembil Research Institute at University Health Network (UHN).
Nov 26, 2021
In collaboration with the University of Toronto Temerty Faculty of Medicine, the Toronto Dementia Research Alliance (TDRA) and the Tanz Centre for Research in Neurodegenerative Diseases partnered to launch a seed funding competition.
Oct 26, 2021
A team led by University of Toronto researchers has prevented the development of brain changes and movement problems associated with Parkinson's disease in mice. Using a new approach, the research team reduced the levels of a protein that causes Parkinson’s.